Answering the call to address the COVID-19 pandemicBehind every laboratorian is the support of 53,000 Healthineers

To enable an effective vaccination strategy, we advocate for the use of accessible, automated, high-throughput SARS-CoV-2 serology testing to help confirm efficacy and promote public health. Siemens Healthineers formulated a position paper based on input from experts in the infectious disease, immunology and vaccine development fields and the currently available body of literature.

Siemens Healthineers Position Statement on SARS-CoV-2 Serology Testing in the Setting of Vaccination (pdf)